SFDA Grants GLP Certification to WuXi Suzhou Toxicology Facility

The State Food and Drug Administration (SFDA) has granted a certificate of Good Laboratory Practice (GLP) to WuXi PharmaTech’s toxicology facility in Suzhou, Jiangsu, China. The certification will allow WuXi to carry out non-clinical laboratory studies with respect to the requirements of the Chinese Food and Drug Act and SFDA GLP regulations.
Pharmaceutical Business Review